Logo
Whalesbook
HomeStocksNewsPremiumAbout UsContact Us

Aequs IPO Explodes: Over 18X Subscribed! Retail Frenzy & Skyrocketing GMP Hint at Blockbuster Listing!

Industrial Goods/Services|5th December 2025, 6:16 AM
Logo
AuthorAditi Singh | Whalesbook News Team

Overview

The Aequs IPO, seeking to raise Rs 922 crore, has garnered immense investor attention, closing oversubscribed more than 18 times its offer size on the final day. Retail investors showed exceptional demand, subscribing over 45 times their quota. Ahead of listing, the company's unlisted shares traded at a strong grey market premium (GMP) of around 33-34%. The IPO comprises a fresh issue of Rs 670 crore and an offer-for-sale of Rs 251.81 crore, with a price band of Rs 118-124 per share. Proceeds will primarily reduce debt.

Aequs IPO Explodes: Over 18X Subscribed! Retail Frenzy & Skyrocketing GMP Hint at Blockbuster Listing!

Aequs' Rs 922-crore Initial Public Offering (IPO) has concluded with overwhelming investor interest, subscribed over 18 times its offer size by the final day of bidding. Strong demand, particularly from retail investors, and a significant grey market premium (GMP) suggest a potentially strong listing.

The IPO, open from December 3 to December 5, attracted bids for nearly 77.58 crore shares against an offer size of 4.20 crore. Retail investors exhibited remarkable enthusiasm, booking their reserved portion more than 45 times. Non-Institutional Investors (NIIs) subscribed over 35 times their quota, while Qualified Institutional Buyers (QIBs) subscribed 78% of their allotted portion.

Grey Market Premium (GMP)

Ahead of its stock exchange debut, Aequs' unlisted shares were trading at a substantial grey market premium. Data from Investorgain indicated a GMP of around 33.87%, while IPO Watch reported a 34.67% premium over the IPO price band of Rs 118-124. This premium indicates strong market sentiment and anticipation for the company's performance post-listing.

IPO Structure and Financial Strategy

Aequs aimed to raise approximately Rs 922 crore through a combination of a fresh issue of Rs 670 crore and an offer-for-sale (OFS) of Rs 251.81 crore. A significant portion of the IPO proceeds, Rs 433 crore, is earmarked for debt repayment. This strategic move is expected to significantly reduce the company's interest burden and improve its near-term profitability.

Company Profile and Business Operations

Aequs is a contract manufacturing firm with operations spanning consumer durables, plastics, and advanced aerospace components. The company holds a leading position in vertically integrated aerospace component manufacturing within a Special Economic Zone (SEZ), serving global Original Equipment Manufacturers (OEMs) such as Airbus, Boeing, and Safran. Its aerospace segment reported consistent operational profitability with 19.4% EBITDA margins in FY25.

Analyst Views and Valuation

Analysts have noted Aequs' strong structural advantages in India's aerospace precision manufacturing sector. Abhinav Tiwari from Bonanza highlighted its leading position and service to global OEMs. He pointed out that debt reduction through IPO proceeds will enable near-term PAT profitability. Angel One assigned a 'Subscribe with caution' rating for long-term investors, citing Aequs' integrated aerospace ecosystem and growth potential. However, they also flagged concerns regarding elevated leverage, continued losses, and the allocation of IPO proceeds primarily towards debt repayment rather than expansion, suggesting a long-term investment perspective.

At the upper price band of Rs 124, Aequs was valued at 9.94 times Price-to-Book (P/B), with Price-to-Earnings (P/E) being irrelevant due to current losses. The valuation reflects its integrated aerospace ecosystem, asset base, and long-cycle growth potential.

Listing Details

Allotments for the IPO are likely to be finalized by December 8, with the shares scheduled to list on the BSE and NSE on December 10.

Impact

  • The strong subscription figures and high GMP suggest robust investor confidence in Aequs and its business model.
  • A successful listing could further invigorate the Indian aerospace and precision manufacturing sectors.
  • The company's focus on debt reduction is viewed positively, enhancing its financial stability and long-term growth prospects.
  • Impact Rating: 8/10

Difficult Terms Explained

  • IPO (Initial Public Offering): The first time a private company offers its shares for sale to the public to raise capital.
  • GMP (Grey Market Premium): The unofficial trading price of an IPO's unlisted shares before they are listed on stock exchanges, indicating market sentiment.
  • Subscription: The process by which investors apply for shares offered in an IPO. An oversubscribed IPO means more shares were applied for than were available.
  • OFS (Offer for Sale): A type of IPO where existing shareholders sell their shares to the public, rather than the company issuing new shares.
  • Retail Investors: Individual investors who apply for shares valued up to Rs 2 lakh in an IPO.
  • NII (Non-Institutional Investors): Investors applying for shares worth more than Rs 2 lakh in an IPO, excluding QIBs and retail investors.
  • QIB (Qualified Institutional Buyers): Large institutional investors such as mutual funds, insurance companies, and foreign institutional investors.
  • OEMs (Original Equipment Manufacturers): Companies that manufacture components or systems used in another company's final product.
  • SEZ (Special Economic Zone): A designated geographical region within a country offering economic incentives and relaxed regulations to attract business and investment.
  • EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization; a measure of a company's operating performance.
  • PAT (Profit After Tax): The net profit a company earns after all expenses, taxes, and interest have been deducted.
  • P/B (Price-to-Book): A valuation ratio comparing a company's market capitalization to its book value.
  • P/E (Price-to-Earnings): A valuation ratio comparing a company's share price to its earnings per share.

No stocks found.


Real Estate Sector

Prestige Estates Stock Surges: Brokerage Reveals MASSIVE 38% Upside Potential!

Prestige Estates Stock Surges: Brokerage Reveals MASSIVE 38% Upside Potential!

RBI Slashes Repo Rate to 5.25%! Home Loan EMIs to Plummet! Borrowers Brace for HUGE Savings & Boosted Property Market!

RBI Slashes Repo Rate to 5.25%! Home Loan EMIs to Plummet! Borrowers Brace for HUGE Savings & Boosted Property Market!

Prestige Estates Poised for Explosive Growth: Motilal Oswal Issues Strong BUY Rating with Huge Target!

Prestige Estates Poised for Explosive Growth: Motilal Oswal Issues Strong BUY Rating with Huge Target!


Brokerage Reports Sector

HDFC Securities Drops CONCOR Options Bomb: Massive Profit Potential Unlocked! See Strategy Now!

HDFC Securities Drops CONCOR Options Bomb: Massive Profit Potential Unlocked! See Strategy Now!

Brokerage Reveals Top 18 'High-Conviction' Stocks: Can They Deliver Stunning 50-200% Returns in 3 Years?

Brokerage Reveals Top 18 'High-Conviction' Stocks: Can They Deliver Stunning 50-200% Returns in 3 Years?

Bajaj Broking's Top Stock Bets REVEALED! Max Healthcare & Tata Power: Buy Signals Issued, Nifty/Bank Nifty Forecast!

Bajaj Broking's Top Stock Bets REVEALED! Max Healthcare & Tata Power: Buy Signals Issued, Nifty/Bank Nifty Forecast!

BSE Stock Set for Massive Surge? Brokerage Initiates 'Buy' With Groundbreaking Target Price!

BSE Stock Set for Massive Surge? Brokerage Initiates 'Buy' With Groundbreaking Target Price!

GET INSTANT STOCK ALERTS ON WHATSAPP FOR YOUR PORTFOLIO STOCKS
applegoogle
applegoogle

More from Industrial Goods/Services

Kaynes Tech Stock Plunges Amid Accounting Scare! Company Fights Back With Crucial Clarifications – What Investors MUST Know!

Industrial Goods/Services

Kaynes Tech Stock Plunges Amid Accounting Scare! Company Fights Back With Crucial Clarifications – What Investors MUST Know!

Aequs IPO EXPLODES: Investor Demand Reaches Fever Pitch, Oversubscribed 22X!

Industrial Goods/Services

Aequs IPO EXPLODES: Investor Demand Reaches Fever Pitch, Oversubscribed 22X!

Africa's Mega Refinery Dream: Dangote Seeks Indian Giants for $20 Billion Powerhouse!

Industrial Goods/Services

Africa's Mega Refinery Dream: Dangote Seeks Indian Giants for $20 Billion Powerhouse!

Samvardhana Motherson Stock Set for Rocket Launch? YES Securities Bets Big with ₹139 Target!

Industrial Goods/Services

Samvardhana Motherson Stock Set for Rocket Launch? YES Securities Bets Big with ₹139 Target!

NIIF Plans $500 Million Sale of IntelliSmart Stake: India's Smart Meter Future in New Hands?

Industrial Goods/Services

NIIF Plans $500 Million Sale of IntelliSmart Stake: India's Smart Meter Future in New Hands?

Vidya Wires IPO Closing Today: Over 13X Subscription & Strong GMP Signal Hot Debut!

Industrial Goods/Services

Vidya Wires IPO Closing Today: Over 13X Subscription & Strong GMP Signal Hot Debut!


Latest News

India's Green Energy Surge: AMPIN Secures $50 Million FMO Investment to Power Renewable Future!

Renewables

India's Green Energy Surge: AMPIN Secures $50 Million FMO Investment to Power Renewable Future!

RBI Rate Cut SHOCKS Market! Sensex, Nifty Surge as Banking, Realty Stocks EXPLODE - What's Next?

Economy

RBI Rate Cut SHOCKS Market! Sensex, Nifty Surge as Banking, Realty Stocks EXPLODE - What's Next?

Meesho IPO Ignites Investor Frenzy: Oversubscribed 16X on Final Day - Is This India's Next Tech Giant?

Tech

Meesho IPO Ignites Investor Frenzy: Oversubscribed 16X on Final Day - Is This India's Next Tech Giant?

US Tariffs Hit Indian Exports Hard! RBI Governor's Surprising Take on 'Minimal Impact' & Opportunity!

Economy

US Tariffs Hit Indian Exports Hard! RBI Governor's Surprising Take on 'Minimal Impact' & Opportunity!

Godrej Consumer Products poised for BIG COMEBACK? Analysts predict strong growth surge!

Consumer Products

Godrej Consumer Products poised for BIG COMEBACK? Analysts predict strong growth surge!

Massive ₹423 Crore Deal: Eris Lifesciences to Fully Own Swiss Parenterals!

Healthcare/Biotech

Massive ₹423 Crore Deal: Eris Lifesciences to Fully Own Swiss Parenterals!